Kura Oncology IncNASDAQ:KURA
- LAST PRICE20.9500
- TODAY'S CHANGE (%)-0.1300 (-0.6167%)
- Bid / Lots20.6500/ 3
- Ask / Lots23.0000/ 11
- Open / Previous Close21.1300 / 21.0800
- Day Range
- 52 Week Range
- Volume995,839
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | KURA |
|---|---|---|
| 09:32 ET | 124583 | 21.1297 |
| 09:38 ET | 200 | 20.96 |
| 09:41 ET | 100 | 20.98 |
| 09:52 ET | 300 | 20.865 |
| 09:59 ET | 1127 | 21.09 |
| 10:01 ET | 600 | 21.255 |
| 10:03 ET | 1705 | 21.19 |
| 10:06 ET | 1317 | 21.065 |
| 10:08 ET | 1369 | 21.19 |
| 10:12 ET | 100 | 21.11 |
| 10:14 ET | 100 | 21.04 |
| 10:15 ET | 500 | 20.995 |
| 10:17 ET | 627 | 21.13 |
| 10:19 ET | 200 | 21.18 |
| 10:21 ET | 500 | 21.2 |
| 10:24 ET | 400 | 21.25 |
| 10:26 ET | 2807 | 21.25 |
| 10:28 ET | 300 | 21.35 |
| 10:30 ET | 400 | 21.35 |
| 10:33 ET | 700 | 21.37 |
| 10:35 ET | 1287 | 21.35 |
| 10:39 ET | 400 | 21.4 |
| 10:42 ET | 100 | 21.38 |
| 10:44 ET | 8266 | 21.37 |
| 10:48 ET | 200 | 21.29 |
| 10:50 ET | 100 | 21.3 |
| 10:51 ET | 380 | 21.2713 |
| 10:53 ET | 727 | 21.31 |
| 10:57 ET | 100 | 21.35 |
| 11:02 ET | 300 | 21.28 |
| 11:06 ET | 217 | 21.28 |
| 11:08 ET | 200 | 21.265 |
| 11:09 ET | 617 | 21.21 |
| 11:11 ET | 584 | 21.19 |
| 11:20 ET | 100 | 21.105 |
| 11:26 ET | 100 | 21.12 |
| 11:27 ET | 433 | 21.12 |
| 11:31 ET | 1591 | 21 |
| 11:33 ET | 900 | 20.95 |
| 11:36 ET | 500 | 20.96 |
| 11:38 ET | 2700 | 20.995 |
| 11:40 ET | 1125 | 21.02 |
| 11:42 ET | 400 | 21.06 |
| 11:44 ET | 1145 | 21.05 |
| 11:45 ET | 717 | 21.14 |
| 11:47 ET | 1011 | 21.115 |
| 11:49 ET | 544 | 21.12 |
| 11:54 ET | 743 | 21.065 |
| 11:56 ET | 2891 | 21.07 |
| 11:58 ET | 300 | 21.08 |
| 12:00 ET | 691 | 21.05 |
| 12:02 ET | 100 | 21.065 |
| 12:05 ET | 300 | 21.08 |
| 12:07 ET | 700 | 21.045 |
| 12:09 ET | 2496 | 21.015 |
| 12:14 ET | 200 | 20.99 |
| 12:18 ET | 819 | 21 |
| 12:21 ET | 103 | 20.99 |
| 12:30 ET | 427 | 20.99 |
| 12:32 ET | 100 | 20.96 |
| 12:34 ET | 200 | 20.9495 |
| 12:38 ET | 677 | 20.99 |
| 12:41 ET | 700 | 21 |
| 12:43 ET | 100 | 20.98 |
| 12:48 ET | 100 | 20.99 |
| 12:50 ET | 100 | 21 |
| 12:52 ET | 1032 | 21.015 |
| 12:54 ET | 903 | 21.035 |
| 12:57 ET | 700 | 21.01 |
| 12:59 ET | 738 | 21.02 |
| 01:01 ET | 200 | 21.03 |
| 01:03 ET | 100 | 21.05 |
| 01:06 ET | 319 | 21 |
| 01:08 ET | 1100 | 21.05 |
| 01:10 ET | 4100 | 21.09 |
| 01:14 ET | 300 | 21.095 |
| 01:15 ET | 600 | 21.16 |
| 01:17 ET | 700 | 21.12 |
| 01:19 ET | 600 | 21.1275 |
| 01:21 ET | 2300 | 21.08 |
| 01:24 ET | 500 | 21.07 |
| 01:26 ET | 100 | 21.08 |
| 01:28 ET | 1135 | 21.06 |
| 01:30 ET | 400 | 21.09 |
| 01:32 ET | 200 | 21.07 |
| 01:33 ET | 700 | 21.045 |
| 01:35 ET | 1000 | 21.035 |
| 01:37 ET | 300 | 21.055 |
| 01:39 ET | 100 | 21.1 |
| 01:42 ET | 300 | 21.08 |
| 01:44 ET | 1466 | 21.06 |
| 01:46 ET | 500 | 21.14 |
| 01:48 ET | 2129 | 21.0675 |
| 01:50 ET | 400 | 21.05 |
| 01:51 ET | 500 | 21.05 |
| 01:53 ET | 100 | 21.05 |
| 01:55 ET | 100 | 21.05 |
| 01:57 ET | 427 | 21 |
| 02:00 ET | 400 | 20.985 |
| 02:02 ET | 100 | 21 |
| 02:04 ET | 519 | 21.03 |
| 02:06 ET | 300 | 21 |
| 02:08 ET | 450 | 21.02 |
| 02:09 ET | 100 | 21.01 |
| 02:11 ET | 200 | 21.01 |
| 02:13 ET | 720 | 21 |
| 02:15 ET | 545 | 21.05 |
| 02:18 ET | 400 | 21.02 |
| 02:20 ET | 200 | 21.025 |
| 02:22 ET | 569 | 21 |
| 02:24 ET | 100 | 20.99 |
| 02:26 ET | 100 | 20.98 |
| 02:27 ET | 200 | 20.98 |
| 02:29 ET | 400 | 20.98 |
| 02:31 ET | 300 | 20.98 |
| 02:33 ET | 100 | 20.99 |
| 02:36 ET | 200 | 20.98 |
| 02:38 ET | 600 | 20.98 |
| 02:40 ET | 300 | 21 |
| 02:42 ET | 200 | 21.01 |
| 02:44 ET | 100 | 21.04 |
| 02:45 ET | 613 | 21.03 |
| 02:47 ET | 300 | 21.05 |
| 02:49 ET | 680 | 21.07 |
| 02:51 ET | 200 | 21.03 |
| 02:54 ET | 1700 | 21.02 |
| 02:56 ET | 400 | 21.01 |
| 02:58 ET | 300 | 21.01 |
| 03:00 ET | 715 | 20.975 |
| 03:02 ET | 200 | 21.01 |
| 03:03 ET | 1800 | 20.99 |
| 03:05 ET | 200 | 20.99 |
| 03:07 ET | 388 | 20.98 |
| 03:09 ET | 923 | 20.93 |
| 03:12 ET | 400 | 20.94 |
| 03:14 ET | 3283 | 20.99 |
| 03:16 ET | 1319 | 20.95 |
| 03:18 ET | 1200 | 20.9 |
| 03:20 ET | 977 | 20.93 |
| 03:21 ET | 513 | 20.94 |
| 03:23 ET | 657 | 20.93 |
| 03:25 ET | 300 | 20.96 |
| 03:27 ET | 400 | 20.945 |
| 03:30 ET | 1300 | 20.99 |
| 03:32 ET | 800 | 20.97 |
| 03:34 ET | 1000 | 20.96 |
| 03:36 ET | 5230 | 20.94 |
| 03:38 ET | 812 | 20.95 |
| 03:39 ET | 800 | 21.015 |
| 03:41 ET | 1344 | 20.98 |
| 03:43 ET | 1200 | 20.99 |
| 03:45 ET | 1100 | 21 |
| 03:48 ET | 500 | 20.97 |
| 03:50 ET | 3355 | 20.99 |
| 03:52 ET | 2392 | 20.93 |
| 03:54 ET | 5078 | 20.9 |
| 03:56 ET | 7034 | 20.86 |
| 03:57 ET | 5368 | 20.935 |
| 03:59 ET | 534185 | 20.95 |
Sep 17, 2024
Press Release: Kura Oncology Appoints Michael Vasconcelles, M.D., to Board of Directors, from 7:30AM ET on Tuesday Sep 17, 2024 by Dow Jones
7:30AM ET on Tuesday Sep 17, 2024 by Dow JonesKura Oncology Appoints Michael Vasconcelles, M.D., to Board of Directors, from 7:30AM ET on Tuesday Sep 17, 2024 by Dow Jones
7:30AM ET on Tuesday Sep 17, 2024 by Dow Jones
Sep 10, 2024
Kura Oncology to Participate in Cantor Global Healthcare Conference, from 7:30AM ET on Tuesday Sep 10, 2024 by Dow Jones
7:30AM ET on Tuesday Sep 10, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Kura Oncology Inc | 1.6B | -9.4x | --- |
Syndax Pharmaceuticals Inc | 1.6B | -5.4x | --- |
Spyre Therapeutics Inc | 1.5B | -2.0x | --- |
Viridian Therapeutics Inc | 1.7B | -5.3x | --- |
Belite Bio Inc | 1.5B | -39.5x | --- |
Cassava Sciences Inc | 1.5B | -73.5x | --- |
Company Information
Kura Oncology, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on precision medicine for the treatment of cancer. Its pipeline consists of small molecule product candidates that target cancer signaling pathways. Its product candidates include Ziftomenib, Tipifarnib and KO-2806. Ziftomenib, is a potent, selective, reversible and oral small molecule inhibitor that blocks the interaction of two proteins, menin and the protein expressed by the Lysine K-specific Methyl Transferase 2A gene, or KMT2A gene. Ziftomenib is a once-daily, oral drug candidate targeting the menin-KMT2A protein-protein interaction for the treatment of genetically defined acute myeloid leukemia patients with high unmet need. Tipifarnib is a potent, selective and orally bioavailable farnesyl transferase inhibitor (FTI). The KO-2806 is a next-generation FTI, which demonstrates improved potency, pharmacokinetic and physicochemical properties relative to earlier FTI drug candidates.
Contact Information
- Headquarters
- 12730 HIGH BLUFF DRIVE, SUITE 400SAN DIEGO, CA, United States 92130
- Phone
- 858-500-8800
- Fax
- 302-655-5049
Executives
- Chairman of the Board, President, Chief Executive Officer
- Troy Wilson
- Chief Operating Officer
- Kathleen Ford
- Chief Medical Officer
- Stephen Dale
- Chief Commercial Officer
- Brian Powl
- Chief Legal Officer, Secretary
- Teresa Bair
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.6B |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 76.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.84 |
EPS | $-2.23 |
Book Value | $5.34 |
P/E Ratio | -9.4x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
